IS
IS · IS · IS-EU/1/22/1704/006
Livmarli
ATC A05AX04
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerMirum Pharmaceuticals International B.V.
CountryIS (IS)
ATC codeA05AX04
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tafla",
"source": "lyfjastofnun",
"atc_raw": "A05AX04",
"marketed": false,
"strength": "30 mg",
"ma_number": "EU/1/22/1704/006",
"substance": "Maralixibat",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í meltingarsjúkdómum barna og fullorðinna.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "46071"
}Related drugs
Other records sharing ATC code A05AX04.
- ISLivmarliMirum Pharmaceuticals International B.V.
- ISLivmarliMirum Pharmaceuticals International B.V.
- ISLivmarliMirum Pharmaceuticals International B.V.
- ISLivmarliMirum Pharmaceuticals International B.V.
- ISLivmarliMirum Pharmaceuticals International B.V.
- PLLivmarliMirum Pharmaceuticals International B.V.
- DKLivmarliMirum Pharmaceuticals International B.V.
- DKLivmarliMirum Pharmaceuticals International B.V.
Access this data programmatically
Query Livmarli and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.